Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for +publisher:"Rutgers University" +contributor:("Noll, Katia Sutyak, 1983-"). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Rutgers University

1. Noll, Katia Sutyak, 1983-. The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis.

Degree: PhD, Microbiology and Molecular Genetics, 2010, Rutgers University

Bacterial vaginosis (BV) is a condition characterized by an imbalance in the vaginal microflora where healthy lactobacilli are replaced by anaerobic microorganisms, especially Gardnerella vaginalis. It is estimated that 10-30% of North American women suffer from BV, frequently requiring medical attention. Proliferation of BV-associated organisms is known to have pathogenic effects, particularly in pregnant women. BV is associated with development of pelvic inflammatory disease, low fetal birth weight, preterm births with an elevated risk of infant death, intra-amniotic infections leading to fetal brain damage, and spontaneous abortion. Furthermore, BV (and G. vaginalis in particular) has been shown to increase the probability of contracting HIV and to stimulate viral replication. The antibiotics commonly prescribed to treat BV cause widespread inhibition of the healthy vaginal microflora, leading to a 20% recurrence rate of infection, often with newly developed antibiotic resistance(s). One promising alternative BV treatment is the bacteriocin, or antimicrobial peptide, subtilosin A. This dissertation describes the isolation, characterization, and purification of subtilosin from a fermented dairy product isolate of B. amyloliquefaciens. This is the first report of the intra-species horizontal gene transfer of subtilosin (from B. subtilis), and it is the first bacteriocin characterized from B. amyloliquefaciens. Via well diffusion assays, subtilosin was found to inhibit several human pathogens, including G. vaginalis, but has no effect on healthy vaginal lactobacilli. Motility and structure analyses of human spermatozoa revealed subtilosin possesses potent spermicidal activity. In vitro ectocervical tissue toxicity testing showed subtilosin is completely safe for human tissues. Elucidation of the molecular mechanism of action established that subtilosin specifically inhibits G. vaginalis by forming pores in the cell membrane, causing an efflux of ATP and dissipation of the delta pH portion of the proton motive force. Finally, microplate checkerboard assays confirmed that subtilosin acts synergistically with other antimicrobials of varying mechanisms of action, suggesting that lower concentrations of subtilosin could be used to effectively inhibit G. vaginalis, thereby decreasing the likelihood of developing resistance. Taken together, the data presented herein demonstrate that subtilosin is a safe, natural antimicrobial peptide that can easily be formulated into an effective prophylaxis or treatment for bacterial vaginosis.

Advisors/Committee Members: Noll, Katia Sutyak, 1983- (author), Chikindas, Michael (chair), Matthews, Karl R. (internal member), Woychik, Nancy (internal member), Dedova, Olga (outside member).

Subjects/Keywords: Vagina – Diseases; Vagina – Microbiology; Bacteriocins; Anti-infective agents

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Noll, Katia Sutyak, 1. (2010). The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis. (Doctoral Dissertation). Rutgers University. Retrieved from http://hdl.rutgers.edu/1782.1/rucore10001600001.ETD.000056635

Chicago Manual of Style (16th Edition):

Noll, Katia Sutyak, 1983-. “The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis.” 2010. Doctoral Dissertation, Rutgers University. Accessed May 09, 2021. http://hdl.rutgers.edu/1782.1/rucore10001600001.ETD.000056635.

MLA Handbook (7th Edition):

Noll, Katia Sutyak, 1983-. “The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis.” 2010. Web. 09 May 2021.

Vancouver:

Noll, Katia Sutyak 1. The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis. [Internet] [Doctoral dissertation]. Rutgers University; 2010. [cited 2021 May 09]. Available from: http://hdl.rutgers.edu/1782.1/rucore10001600001.ETD.000056635.

Council of Science Editors:

Noll, Katia Sutyak 1. The safe, natural antimicrobial peptide subtilosin for control of bacterial vaginosis. [Doctoral Dissertation]. Rutgers University; 2010. Available from: http://hdl.rutgers.edu/1782.1/rucore10001600001.ETD.000056635

.